NCT00017927View on ClinicalTrials.gov

A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 30, 2001

Study Completion Date

June 30, 2005

Conditions
McCune Albright SyndromePolyostotic Fibrous Dysplasia
Interventions
DRUG

Pegvisomant

Trial Locations (1)

20892

National Institute of Dental And Craniofacial Research (NIDCR), Bethesda

All Listed Sponsors
lead

National Institute of Dental and Craniofacial Research (NIDCR)

NIH

NCT00017927 - A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome | Biotech Hunter | Biotech Hunter